Mid-Atlantic Section of the American Urological Association (MAAUA) Search MA-AUA
Mid-Atlantic Section of the American Urological Association (MAAUA)
Home | About Us | Contact Us   
  Home
  Members
    Members Only Area
    Member Directory
    Join the MA-AUA
  Annual Meeting
  Future Meetings
  Board of Directors
  Committees
  Careers
  Newsletters
  Visit the AUA
  Advocacy Efforts

 
  Members Only
  Username
 
  Password
 
   Forgot Password?

 
 

67th Annual Meeting Abstracts


Flash Replenishment Imaging with Contrast-enhanced Ultrasound Identifies High Volume / High Grade Prostate Cancer
Steve Dong, *Ethan Halpern, *Flemming Forsberg, Leonard Gomella, Edouard Trabulsi
Thomas Jefferson University, Philadelphia, PA

Introduction: To evaluate the detection of prostate cancer using contrast-enhanced ultrasound with an advanced flash replenishment technique - MicroFlow Imaging (MFI).
Materials & Methods: 136 patients referred for prostate biopsy were evaluated by transrectal US. The microbubble agent Definity (Bristol-Myers Squibb) was diluted into concentration of 49.4uL/mL and infused at a rate of 4 mL/min. MFI uses high power flash pulses to destroy bubbles, followed by low power pulses to demonstrate contrast replenishment and depict vascular architecture. Up to 6 targeted biopsy cores were obtained from areas of abnormal vascular enhancement or morphology on MFI, followed by a systematic 12 core biopsy protocol.
Results: Enhancement of capsular and intraprostatic vessels was observed in all patients. Positive biopsies were obtained in 137/1632 (8.4%) of systematic cores and 93/555 (16.8%) of targeted cores (OR=3.3, p<0.001). Among the 49 patients detected by systematic biopsy, those 30 patients with a positive targeted core demonstrated an average of 3.7 positive systematic cores while those 19 patients who were missed by targeted biopsy demonstrated an average of 1.5 positive systematic cores (p=0.001). Mean percentage of systematic biopsy core involvement was 32% among patients with a positive targeted core, compared with 15% among patients who were missed by targeted biopsy (p=0.01). Higher grade cancer (Gleason score >6) was more common among patients with a positive targeted biopsy (47% versus 16%; p=0.03).
Conclusions: Targeted biopsy of the prostate using contrast-enhanced MFI imaging of the prostate identifies high volume/grade cancers which are most likely to be clinically significant.


 

 

 
     
     
Copyright © 2010 Mid-Atlantic Section of the American Urological Association. All Rights Reserved.
Read Privacy Policy.